By using this site, you agree to the IDC Privacy Policy

Dec 2016 - Perspective - Doc # US42042415

Perspective: Changing Times in Commercial Life Science IT — How a Trump Administration Will Affect Current and Future Initiatives

By: Michael TownsendResearch Manager, Life Sciences Commercial Strategies

Abstract

This IDC Health Insights Perspective examines the impact of a Trump administration on commercial life science IT. Donald Trump campaigned on his intention to "repeal and replace" the Patient Protection and Affordable Care Act, commonly referred to as the ACA or "Obamacare," along with several other proposals, which will have a major impact on life science companies and the IT vendors that serve them. Republican majorities in the U.S. House of Representatives and Senate may be poised to turn his campaign promises into legislation with far-reaching effects on the nation's healthcare system.


Coverage

Content


Get More

When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.



Related Links

Do you have questions about this document
or available subscriptions?

Contact Us